cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. It owns and operates consumer hemp-based CBD brands, such as cbdMD and Paw CBD. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. The company also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name. It distributes its products through its e-commerce Website, third party e-commerce sites, wholesalers, and various brick and mortar retailers in the United States. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. was founded in 2015 and is headquartered in Charlotte, North Carolina.
IPO Year: 2017
Exchange: AMEX
Website: cbdmd.com
Charlotte, North Carolina--(Newsfile Corp. - November 14, 2024) - cbdMD, Inc. (NYSE:YCBD) (NYSE:YCBD) a trusted leader in the wellness and cannabinoid industry, is excited to announce the launch of Herbal Oasis Social Tonics—a carefully crafted low-calorie, hemp derived THC seltzer line designed to elevate social occasions with a blend of premium cannabinoids and adaptogenic mushrooms. Available in four delicious flavors—Lemon Lift, Tropical Twist, Mango Bliss, and Berry Fusion—Herbal Oasis is designed to deliver an experience that enhances social connection and well-being, offering an alternative to traditional alcoholic drinks.As the first entry of its kind for cbdMD, the Company believes
Company is creating its own wine. Capitalizing on the projected $2.1 billion U.S. CBD-infused beverage market by 2025, CBDL positions itself at the forefront of innovation, unlocking immense revenue potential in the booming CBD alcohol sector. SCOTTSDALE, AZ / ACCESSWIRE / November 13, 2024 / CBD Life Sciences Inc. (OTC:CBDL), a pioneer in the CBD wellness industry, is thrilled to announce its application for a beer and liquor license, paving the way for its entry into the CBD-infused wine market. This groundbreaking initiative is set to diversify the company's offerings and tap into one of the fastest-growing segments in the cannabis and alcohol industries. Market Opportunity and Revenue
Walmart's market cap as of September 2024 is $635.50 billion, making it the 13th most valuable company in the world. This partnership offers CBD Life Sciences unprecedented exposure on a global retail platform.SCOTTSDALE, AZ / ACCESSWIRE / October 22, 2024 / CBD Life Sciences, Inc. (OTC:CBDL) proudly announces a monumental step forward in its rapid growth trajectory-approval to sell its signature 3000MG Pain Relief Cream on Walmart Marketplace. This landmark achievement not only marks a new era of accessibility for consumers but also signals CBD Life Sciences' aggressive push to dominate the multibillion-dollar CBD market. With more top-selling products set to launch on Walmart's expansive e
CBD Life Sciences propels its expansion with a major MOU, positioning the company for multi-million-dollar growth in the booming $14.6 billion adaptogens market.SCOTTSDALE, AZ / ACCESSWIRE / October 15, 2024 / CBD Life Sciences, Inc. (OTC:CBDL) is excited to announce the signing of a game-changing Memorandum of Understanding (MOU) with a division of the United States Armed Forces, marking a pivotal moment in the company's journey toward revolutionizing health and performance solutions. While the details of the agreement are confidential, this partnership could position CBDL at the forefront of high-performance health solutions, creating a massive opportunity for growth and expansion in the n
Leveraging Alibaba's 1.28 billion annual active consumers and $3 trillion in gross merchandise volume to accelerate growth and global market penetration.SCOTTSDALE, AZ / ACCESSWIRE / October 10, 2024 / CBD Life Sciences Inc. (OTC:CBDL), a trailblazer in the CBD industry, proudly announces a bold new step in its expansion strategy by targeting Alibaba, the world's largest retail and e-commerce platform. With an eye on global dominance, CBDL is set to offer its top-selling CBD products to Alibaba's vast wholesale marketplace, unlocking access to over 1.28 billion annual active consumers and an astounding $3 trillion in gross merchandise volume (GMV). This move marks a significant milestone in
"Record-breaking revenue, new market entries, and transformative partnerships highlight our path to increasing shareholder value and long-term growth."SCOTTSDALE, AZ / ACCESSWIRE / October 8, 2024 / Dear Shareholders,2024 has been a banner year for CBD Life Sciences, Inc. (CBDL), and we are thrilled to provide you with an exciting corporate update that underscores the massive growth and strategic advancements that are rapidly transforming our business. As of February 2024, we have achieved an extraordinary 1,405.46% increase in revenue, our highest to date, cementing CBDL as a dominant player in the booming CBD and wellness sectors. This remarkable growth was driven by our aggressive expa
The annual economic impact of the equine industry is significant - involving some $300 billion dollars and 1.6 million full-time jobs. CBD Life Sciences' Groundbreaking Horse Paste is Set to Transform the Industry and Drive Explosive GrowthSCOTTSDALE, AZ / ACCESSWIRE / October 3, 2024 / CBD Life Sciences, Inc. (CBDL), an industry leader in innovative CBD solutions, proudly announces the launch of its latest product, the CBD Horse Paste. This veterinarian-designed formulation is the first of its kind, offering unparalleled support for horses facing both physical and psychological challenges. A Game-Changer in the Equine Wellness MarketEquine health concerns such as muscle stiffness, joi
RangeMe connects CBDL to over 200,000 retail buyers, including some of the world's largest retailers, driving exponential market opportunitiesSCOTTSDALE, AZ / ACCESSWIRE / October 2, 2024 / CBD Life Sciences Inc. (OTC:CBDL), a trailblazer in the booming CBD industry, today announces a strategic leap in expanding its revenue channels by partnering with RangeMe, the premier product discovery and sourcing platform. With access to over 200,000 retail buyers, including key players from leading global retailers, this move sets the stage for monumental growth, further propelling CBDL into the spotlight as a top contender in the CBD market. As consumer demand for premium CBD products skyrockets, C
With Amazon's market value increasing by more than $400 billion in 2024, CBD Life Sciences Inc. is poised for new revenue growth with top-selling CBD Pain Relief Roll-On and Pet Treats.SCOTTSDALE, AZ / ACCESSWIRE / October 1, 2024 / CBD Life Sciences Inc. (OTC:CBDL), a fast-growing leader in the CBD industry, is excited to announce its application to list on Amazon Marketplace. Following its successful launch on Walmart Marketplace, this strategic expansion promises to significantly increase the company's e-commerce footprint, offering its top-selling CBD Pain Relief Cream Roll-On and CBD Pet Treats to millions of Amazon customers globally. The move underscores CBD Life Sciences' commitme
The U.S. CBD consumer health market size was estimated at USD 7.81 billion in 2023 and is projected to surpass around USD 31.11 billion by 2033 at a CAGR of 14.79% from 2024 to 2033 SCOTTSDALE, AZ / ACCESSWIRE / September 26, 2024 / CBD Life Sciences Inc. (OTC:CBDL), a leading innovator in the CBD and wellness industry, is proud to announce an extraordinary revenue increase of 1405.46% since February 2024. This exceptional growth highlights the company's successful strategic initiatives and the increasing market demand for its premium CBD products. "This significant milestone reflects our commitment to innovation, quality, and expanding our market footprint," stated Lisa Nelson, President
Charlotte, North Carolina--(Newsfile Corp. - August 26, 2024) - cbdMD, Inc. (NYSE:YCBD) (NYSE:YCBD), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, along with its functional mushroom brand ATRx Labs, today announced that it received notice from the NYSE American LLC that it had accepted the Company's plan to regain compliance with the NYSE American continued listing standards and granted a plan period through December 5, 2025. As previously disclosed on June 5, 2024, the Company received a letter from the NYSE American stating that the Company was not in compliance with the continued listing standard
cbdMD Achieves Significant Reduction in Operating Loss as Operational Efficiencies Significantly Improve in Q3 2024Charlotte, North Carolina--(Newsfile Corp. - August 14, 2024) - cbdMD, Inc. (NYSE:YCBD) (NYSE:YCBD) one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, along with its new functional mushroom brand ATRx Labs today announced our financial results for our third quarter of fiscal 2024 ending June 30, 2024. This quarter, cbdMD made significant strides in its strategic objectives. Year-over-year, operational losses improved markedly, shrinking from $1.8 million in the third quarter of fiscal 2023 t
Charlotte, North Carolina--(Newsfile Corp. - August 5, 2024) - cbdMD, Inc. (NYSE:YCBD) (NYSE:YCBD), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Wednesday, August 14, 2024, to discuss the company's June 30, 2024 third quarter of fiscal 2024 financial results and business progress.CONFERENCE CALL DETAILSWednesday August 14, 2024, 4:20 p.m. Eastern TimeUSA/Canada:844-763-8274International:647-484-8814Teleconference Replay dial in:USA/Canada:877-344-7529International:412-317-0088Replay Passcode:5067217Webcast/Webcast Replay link - available through August 14, 2025: https://www.
Charlotte, North Carolina--(Newsfile Corp. - June 7, 2024) - cbdMD, Inc. (NYSE:YCBD) (NYSE:YCBD) ,one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, along with its new functional mushroom brand ATRx Labs, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated June 5, 2024, notifying the Company that it is no longer in compliance with NYSE American continued listing standards. Specifically, the letter states that the Company is not in compliance with the continued listing standard set forth in Section 1003(a)(ii) of the NYSE American Company Guide (
Charlotte, North Carolina--(Newsfile Corp. - May 10, 2023) - cbdMD, Inc. (NYSE:YCBD) (NYSE:YCBDPA) one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:15 p.m., Eastern Time, on Monday, May 15, 2023, to discuss the company's March 31, 2023 second quarter of fiscal 2023 financial results and business progress.CONFERENCE CALL DETAILSMonday, May 15, 2023, 4:15 p.m. Eastern TimeUSA/Canada:800-319-4610International:604-638-5340Teleconference Replay dial in:USA/Canada:855-669-9658International:412-317-0088Replay Passcode:0183Webcast/Webcast Replay link - available through May 15, 2024: https://www.gowebcasting.com
Company continues to make headway despite challenging consumer environment.Charlotte, North Carolina--(Newsfile Corp. - February 13, 2023) - cbdMD, Inc. (NYSE:YCBD) (NYSE:YCBDPA), one of the nation's leading and most highly trusted and recognized CBD companies, and operator the leading CBD brands – including its flagship brand cbdMD, and its animal health brand Paw CBD, today announced our first quarter of fiscal 2023 results. For the first quarter of fiscal 2023 Net Loss improved to $3.9 million on sales of $6.1 million as compared to a $19.1 million Net Loss on sales of $9.3 million in the prior year comparative quarter. Year over year saw marked gains in gross margins and continued signi
Charlotte, North Carolina--(Newsfile Corp. - February 6, 2023) - cbdMD, Inc. (NYSE:YCBD) (NYSE:YCBDPA), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces announced today that it will host a conference call at 4:15 p.m., Eastern Time, on Monday, February 13, 2023, to discuss the company's December 31, 2022 first quarter of fiscal 2023 financial results and business progress.CONFERENCE CALL DETAILSMonday, February 13, 2023, 4:15 p.m. Eastern TimeUSA/Canada:800-319-4610International:604-638-5340Teleconference Replay dial in:USA/Canada:855-669-9658International:412-317-0088Replay Passcode:9893Webcast/Webcast Replay link - available through February
Repositions product portfolio with effective, industry leading concentrations now supported by clinical claimsCharlotte, North Carolina--(Newsfile Corp. - December 15, 2022) - cbdMD, Inc. (NYSE:YCBD) (NYSE:YCBDPA), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of three of the leading CBD brands -- its flagship brand cbdMD, its animal health brand Paw CBD, today announced our quarterly and full fiscal financial results for September 30, 2022. While we incurred a GAAP loss from operations of $78.1 million, the loss was mostly attributed to a one-time goodwill impairment charge of $60.9 million. Excluding one-time Goodwill Impairment Charges, we
Charlotte, North Carolina--(Newsfile Corp. - December 14, 2022) - cbdMD, Inc. (NYSE:YCBD) (NYSE American: YCBDpA), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:15 p.m., Eastern Time, on Thursday, December 15, 2022, to discuss the company's September 30, 2022 fourth quarter and fiscal 2022 financial results and business progress.CONFERENCE CALL DETAILSThursday, December 15, 2022, 4:15 p.m. Eastern Time USA/Canada:800-319-4610 International:604-638-5340 Teleconference Replay dial in: USA/Canada:855-669-9658 International:412-317-0088 Replay Passcode:9709 Webcast/Webcast Replay link - available t
Management delivers on operating improvements while investing in future growth. cbdMD board appoints Dr. Sibyl Swift to the Board of Directors to fill Vacancy.Charlotte, North Carolina--(Newsfile Corp. - August 11, 2022) - cbdMD, Inc. (NYSE:YCBD) (NYSE:YCBDPA), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of three of the leading CBD brands -- its flagship brand cbdMD, its animal health brand Paw CBD and its beauty and skincare brand cbdMD Botanicals, today announced our financial results for June 30, 2022. Excluding one-time Goodwill Impairment charges we cut our GAAP operating loss in half from the prior year quarter and made strong sequenti
Cantor Fitzgerald resumed coverage of cbdMD with a rating of Neutral and set a new price target of $3.25 from $4.10 previously
Cantor Fitzgerald reiterated coverage of cbdMD with a rating of Neutral and set a new price target of $4.30 from $3.60 previously
8-K/A - cbdMD, Inc. (0001644903) (Filer)
8-K - cbdMD, Inc. (0001644903) (Filer)
8-K - cbdMD, Inc. (0001644903) (Filer)
8-K/A - cbdMD, Inc. (0001644903) (Filer)
8-K - cbdMD, Inc. (0001644903) (Filer)
10-Q - cbdMD, Inc. (0001644903) (Filer)
8-K - cbdMD, Inc. (0001644903) (Filer)
8-K - cbdMD, Inc. (0001644903) (Filer)
10-Q - cbdMD, Inc. (0001644903) (Filer)
424B3 - cbdMD, Inc. (0001644903) (Filer)
4 - cbdMD, Inc. (0001644903) (Issuer)
4 - cbdMD, Inc. (0001644903) (Issuer)
4 - cbdMD, Inc. (0001644903) (Issuer)
3 - cbdMD, Inc. (0001644903) (Issuer)
4 - cbdMD, Inc. (0001644903) (Issuer)
4 - cbdMD, Inc. (0001644903) (Issuer)
4 - cbdMD, Inc. (0001644903) (Issuer)
4 - cbdMD, Inc. (0001644903) (Issuer)
4 - cbdMD, Inc. (0001644903) (Issuer)
4 - cbdMD, Inc. (0001644903) (Issuer)
Charlotte, North Carolina--(Newsfile Corp. - June 22, 2023) - cbdMD (NYSE:YCBD), one of the nation's leading providers of premium cannabidiol (CBD) products, is delighted to announce the appointment of Dr. Lucille Vega as their new medical advisor. This collaboration marks an exciting chapter for both parties, as they play a pivotal role in educating the public about the numerous benefits of CBD and cbdMD's commitment to quality and transparency.As a brand that's renowned for its commitment to quality and innovation, cbdMD's comprehensive line of products spans across various categories and caters to a diverse range of consumer needs. By partnering with Dr. Vega, a highly qualified and passi
Charlotte, North Carolina--(Newsfile Corp. - January 11, 2023) - cbdMD, Inc. (NYSE:YCBD) (NYSE:YCBDPA), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces the appointment of Shannon Charles as Chief Marketing Officer. Shannon is a veteran in health and wellness with over a decade of success in the Natural Product Industry. She has a proven record in driving growth across B&M retail, warehouse club stores, ecommerce, as well as international markets. Shannon's leadership has supported the successful brand stories of Naturade, NeoCell, and NutraNext, which the latter was ultimately acquired by The Clorox Co during her tenure. "We are thrilled to h
Martin Sumichrast resigns as CEO, Board MemberCharlotte, North Carolina--(Newsfile Corp. - June 13, 2022) - cbdMD, Inc. (NYSE:YCBD) (NYSE:YCBDPA), announced today that Martin Sumichrast has resigned as CEO and member of the Board of Directors, effective immediately. Board member Scott Stephen was named Board Chair and board member Scott Coffman, former co-CEO and the operating company founder, will consult with the Board of Directors in leading the company until a new CEO is named."We appreciate the years of service that Marty has given to our Company since its founding. However, we believe it is in the best interest of cbdMD, our employees, and our investors for him to step down." said Step
SCOTTSDALE, AZ / ACCESSWIRE / June 3, 2021 / Today CBD Life Sciences (OTC:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. is proud to announce that they have appointed Matthew McGee to serve as Chief Marketing Officer of the Company."I am over the top excited to assume the role of Chief Marketing Officer of CBD Life Sciences Inc," Mr. McGee said. "I look forward to growing the current success that CBD Life Sciences has achieved. I couldn't be anymore thankful for this wonderful opportunity, and I look forward to grow the company further, expand sales and bring in more revenue along with more customers as I have already started developing an amazingly effective strategic plan t
SC 13D/A - cbdMD, Inc. (0001644903) (Subject)
SC 13D/A - cbdMD, Inc. (0001644903) (Subject)
SC 13D/A - cbdMD, Inc. (0001644903) (Subject)
SC 13D/A - cbdMD, Inc. (0001644903) (Subject)
SC 13D/A - cbdMD, Inc. (0001644903) (Subject)
SC 13D/A - cbdMD, Inc. (0001644903) (Subject)
SC 13D/A - cbdMD, Inc. (0001644903) (Subject)
SC 13D/A - cbdMD, Inc. (0001644903) (Subject)
GAINERS: Global Hemp Group (OTC:GBHPF) shares closed up 117.39% at $0.04 CordovaCann (OTC:LVRLF) shares closed up 19.90% at $0.06 SOL Glb Inv (OTC:SOLCF) shares closed up 19.40% at $0.06 1933 Industries (OTC:TGIFF) shares closed up 11.81% at $0.01 Global Compliance (OTC:FUAPF) shares closed up 10.37% at $0.00 CLS Holdings USA (OTC:CLSH) shares closed up 6.01% at $0.04 22nd Century Group (NASDAQ:XXII) shares closed up 4.77% at $0.72 EnWave (OTC:NWVCF) shares closed up 4.53% at $0.17 Psychemedics (NASDAQ:PMD) shares closed up 3.52% at $2.24 cbdMD (AMEX:YCBD) shares closed up 3.11% at $0.63 LOSERS: Green Growth Brands (OTC:GGBXF) shares closed down 99.00% at $1e-06 Leafbuyer Techs (OTC:LBUY)
GAINERS: Green Growth Brands (OTC:GGBXF) shares closed up 9900.00% at $0.0001 Rocky Mountain High (OTC:RMHB) shares closed up 33.33% at $0.02 SOL Glb Inv (OTC:SOLCF) shares closed up 19.57% at $0.05 Affinor Growers (OTC:RSSFF) shares closed up 19.12% at $0.08 Pharmadrug (OTC:LMLLF) shares closed up 18.52% at $0.02 1933 Industries (OTC:TGIFF) shares closed up 8.23% at $0.01 Cansortium (OTC:CNTMF) shares closed up 7.14% at $0.15 CV Sciences (OTC:CVSI) shares closed up 7.12% at $0.06 CLS Holdings USA (OTC:CLSH) shares closed up 6.26% at $0.04 Cipher Pharmaceuticals (OTC:CPHRF) shares closed up 5.67% at $6.43 Body and Mind (OTC:BMMJ) shares closed up 5.40% at $0.03 OrganiGram Holdings (NASDAQ:O
GAINERS: Heritage Cannabis Holding (OTC:HERTF) shares closed up 40.00% at $0.00 Elixinol Wellness (OTC:ELLXF) shares closed up 24.00% at $0.00 EnWave (OTC:NWVCF) shares closed up 14.32% at $0.19 Target Group (OTC:CBDY) shares closed up 7.50% at $0.00 Cansortium (OTC:CNTMF) shares closed up 7.12% at $0.13 cbdMD (AMEX:YCBD) shares closed up 5.74% at $0.65 Global Hemp Group (OTC:GBHPF) shares closed up 4.82% at $0.05 Kaya Holdings (OTC:KAYS) shares closed up 3.86% at $0.04 Pharmadrug (OTC:LMLLF) shares closed up 3.85% at $0.01 LOSERS: MJ Holdings (OTC:MJNE) shares closed down 94.74% at $0.0001 CordovaCann (OTC:LVRLF) shares closed down 18.03% at $0.05 Global Compliance (OTC:FUAPF) shares clo
GAINERS: Australis Capital (OTC:AUSAF) shares closed up 9900.00% at $0.0001 Cara Therapeutics (NASDAQ:CARA) shares closed up 25.84% at $0.37 4Front Ventures (OTC:FFNTF) shares closed up 23.42% at $0.10 Cannabix Technologies (OTC:BLOZF) shares closed up 15.92% at $0.43 Global Compliance (OTC:FUAPF) shares closed up 12.75% at $0.01 22nd Century Group (NASDAQ:XXII) shares closed up 11.92% at $0.79 Curaleaf Holdings (OTC:CURLF) shares closed up 9.71% at $4.18 SOL Glb Inv (OTC:SOLCF) shares closed up 9.05% at $0.04 OrganiGram Holdings (NASDAQ:OGI) shares closed up 7.59% at $1.70 RIV Capital (OTC:CNPOF) shares closed up 7.14% at $0.10 GrowGeneration (NASDAQ:GRWG) shares closed up 6.82% at $2.35 A
GAINERS: MJ Holdings (OTC:MJNE) shares closed up 36.54% at $0.00 Kaya Holdings (OTC:KAYS) shares closed up 22.37% at $0.05 Maple Leaf Green World (OTC:MGWFF) shares closed up 11.47% at $0.03 Charlottes Web Holdings (OTC:CWBHF) shares closed up 11.19% at $0.18 Nextleaf Solutions (OTC:OILFF) shares closed up 6.91% at $0.07 Cara Therapeutics (NASDAQ:CARA) shares closed up 6.51% at $0.28 Eastside Distilling (NASDAQ:EAST) shares closed up 4.21% at $1.00 Mexco Energy (AMEX:MXC) shares closed up 3.51% at $11.86 LOSERS: Khiron Life Sciences (OTC:KHRNF) shares closed down 99.00% at $1e-06 The Flowr (OTC:FLWPF) shares closed down 99.00% at $1e-06 Affinor Growers (OTC:RSSFF) shares closed down 45.18
GAINERS: Heritage Cannabis Holding (OTC:HERTF) shares closed up 66.67% at $0.001 Global Compliance (OTC:FUAPF) shares closed up 31.39% at $0.01 Global Hemp Group (OTC:GBHPF) shares closed up 29.87% at $0.03 Zelira Therapeutics (OTC:ZLDAF) shares closed up 21.73% at $0.23 4Front Ventures (OTC:FFNTF) shares closed up 14.45% at $0.08 Greenlane Hldgs (NASDAQ:GNLN) shares closed up 13.74% at $0.27 MariMed (OTC:MRMD) shares closed up 9.94% at $0.19 Zoned Props (OTC:ZDPY) shares closed up 9.91% at $0.66 iAnthus Capital Hldgs (OTC:ITHUF) shares closed up 8.82% at $0.02 Aurora Cannabis (NASDAQ:ACB) shares closed up 8.42% at $4.90 Emeren Group (NYSE:SOL) shares closed up 7.14% at $1.62 OrganiGram Hol
GAINERS: GreenGro Technologies (OTC:GRNH) shares closed up 900.00% at $1e-05 CordovaCann (OTC:LVRLF) shares closed up 50.89% at $0.07 1933 Industries (OTC:TGIFF) shares closed up 47.06% at $0.01 Kaya Holdings (OTC:KAYS) shares closed up 29.70% at $0.04 Target Group (OTC:CBDY) shares closed up 24.28% at $0.00 Global Compliance (OTC:FUAPF) shares closed up 23.20% at $0.01 MJ Holdings (OTC:MJNE) shares closed up 22.41% at $0.00 CV Sciences (OTC:CVSI) shares closed up 19.77% at $0.06 Pharmadrug (OTC:LMLLF) shares closed up 11.11% at $0.01 4Front Ventures (OTC:FFNTF) shares closed up 10.95% at $0.07 Eastside Distilling (NASDAQ:EAST) shares closed up 7.29% at $0.97 Genetic Technologies (NASDAQ:GE
GAINERS: Plant Based Investment (OTC:CWWBF) shares closed up 9900.00% at $0.0001 Elixinol Wellness (OTC:ELLXF) shares closed up 26.00% at $0.00 Maple Leaf Green World (OTC:MGWFF) shares closed up 20.87% at $0.03 Global Hemp Group (OTC:GBHPF) shares closed up 10.82% at $0.04 Charlottes Web Holdings (OTC:CWBHF) shares closed up 10.58% at $0.20 1933 Industries (OTC:TGIFF) shares closed up 8.11% at $0.01 Trulieve Cannabis (OTC:TCNNF) shares closed up 6.16% at $10.51 22nd Century Group (NASDAQ:XXII) shares closed up 5.63% at $0.79 Zoned Props (OTC:ZDPY) shares closed up 5.26% at $0.65 RIV Capital (OTC:CNPOF) shares closed up 5.21% at $0.10 Cresco Labs (OTC:CRLBF) shares closed up 5.00% at $1.78
GAINERS: Global Hemp Group (OTC:GBHPF) shares closed up 75.00% at $0.07 Global Compliance (OTC:FUAPF) shares closed up 47.12% at $0.01 Elixinol Wellness (OTC:ELLXF) shares closed up 41.18% at $0.00 Kaya Holdings (OTC:KAYS) shares closed up 19.21% at $0.04 SOL Glb Inv (OTC:SOLCF) shares closed up 18.99% at $0.06 CLS Holdings USA (OTC:CLSH) shares closed up 18.28% at $0.06 Cansortium (OTC:CNTMF) shares closed up 13.33% at $0.17 Psychemedics (NASDAQ:PMD) shares closed up 12.00% at $2.27 RIV Capital (OTC:CNPOF) shares closed up 11.22% at $0.12 EnWave (OTC:NWVCF) shares closed up 7.35% at $0.18 1933 Industries (OTC:TGIFF) shares closed up 5.56% at $0.01 iAnthus Capital Hldgs (OTC:ITHUF) shares c
cbdMD, Inc. (NYSE:YCBD) (NYSE:YCBD) ,one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, along with its new functional mushroom brand ATRx Labs, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated June 5, 2024, notifying the Company that it is no longer in compliance with NYSE American continued listing standards. Specifically, the letter states that the Company is not in compliance with the continued listing standard set forth in Section 1003(a)(ii) of the NYSE American Company Guide (the "Company Guide"). Section 1003(a)(ii) requires a listed c